Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

677
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
677
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

48.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
48.8K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

579
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
579
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.8K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.8K
Causality in Epidemiology01:21

Causality in Epidemiology

1.3K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.3K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

99
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
99

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Initial Antiretroviral Third-Drug Class and Time to Loss of Virologic Suppression: A Real-World Colombian Cohort Study.

Journal of the International Association of Providers of AIDS Care·2026
Same author

National representative survey of pretreatment HIV drug resistance in Colombia: analysis of antiretroviral resistance-associated mutations using next-generation sequencing.

The Journal of antimicrobial chemotherapy·2025
Same author

Benefits of INSTI-Based Regimens in a Real-World Setting of People Living With HIV-1 in Colombia.

International journal of microbiology·2025
Same author

Applying implementation science frameworks to identify factors that influence the intention of healthcare providers to offer PrEP care and advocate for PrEP in HIV clinics in Colombia: a cross-sectional study.

Implementation science communications·2022
Same author

AC-2020-12-1420.R1 - HIV care providers' familiarity, concerns, and attitudes about HIV PrEP in Colombia: insights from the PrEP-Col-Study.

AIDS care·2022
Same author

<i>Candida auris</i> infection in the central catheter of a patient without sepsis symptoms.

Colombia medica (Cali, Colombia)·2020
Same journal

Intracranial hypertension due to Epstein-Barr virus encephalitis during the postpartum period.

Colombia medica (Cali, Colombia)·2026
Same journal

Reference values for sit-to-stand tests in Colombian adults: a multicenter cross-sectional study.

Colombia medica (Cali, Colombia)·2026
Same journal

Factors influencing COVID-19 vaccination acceptance when knowing potential side effects: a study in Colombia.

Colombia medica (Cali, Colombia)·2026
Same journal

Review on transdermal patches: optimization in drug administration.

Colombia medica (Cali, Colombia)·2026
Same journal

Global Health in the Age of Trumpism.

Colombia medica (Cali, Colombia)·2026
Same journal

Osteometric analysis of the intertubercular sulcus of the humerus.

Colombia medica (Cali, Colombia)·2026
See all related articles

Related Experiment Video

Updated: Dec 6, 2025

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
08:14

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Published on: October 6, 2015

10.5K

COVID-19 and VIH.

María Paulina Posada-Vergara1, Juan Carlos Alzate-Ángel1,2, Ernesto Martínez-Buitrago1,3,4,5

  • 1Grupo VIHCOL, Cali, Colombia.

Colombia Medica (Cali, Colombia)
|October 5, 2020
PubMed
Summary
This summary is machine-generated.

People with HIV did not experience worse COVID-19 outcomes than expected, despite immunosuppression. Research explores factors like antiretrovirals and offers prevention strategies for HIV-COVID-19 co-infection.

Keywords:
COVID-19HIVSARS viruscoinfection

More Related Videos

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
06:46

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals

Published on: January 5, 2016

17.7K
Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
11:14

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

Published on: October 12, 2018

9.5K

Related Experiment Videos

Last Updated: Dec 6, 2025

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
08:14

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Published on: October 6, 2015

10.5K
Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
06:46

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals

Published on: January 5, 2016

17.7K
Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
11:14

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

Published on: October 12, 2018

9.5K

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Background:

  • COVID-19 disproportionately affects individuals with comorbidities like diabetes, obesity, and cardiovascular disease.
  • Persons with human immunodeficiency virus (HIV) were anticipated to face severe COVID-19 due to immunosuppression.
  • Observed outcomes in HIV-positive individuals during the pandemic have presented a paradox, prompting further investigation.

Purpose of the Study:

  • To review the epidemiology and clinical characteristics of COVID-19 in individuals with HIV.
  • To discuss potential factors, including antiretroviral therapy, influencing the clinical course of HIV-COVID-19 co-infection.
  • To analyze pandemic-related risks for people with HIV and provide care recommendations.

Main Methods:

  • Literature review of existing data on HIV-COVID-19 co-infection.
  • Analysis of epidemiological trends and clinical outcomes.
  • Synthesis of evidence regarding influencing factors and risk determinants.

Main Results:

  • Contrary to expectations, persons with HIV have not shown a consistently higher susceptibility or poorer outcomes for COVID-19.
  • Hypotheses regarding the protective role of immunosuppression or antiretroviral use are being explored.
  • Other pandemic-related factors may negatively impact individuals with HIV.

Conclusions:

  • The clinical evolution of COVID-19 in people with HIV requires further study to understand the observed paradox.
  • Evidence-based recommendations are needed for the prevention and management of COVID-19 in the context of HIV care.
  • Understanding these dynamics is crucial for optimizing public health strategies during pandemics.